SUNNYVALE, Calif., Feb 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Accuray Incorporated (Nasdaq: ARAY) today announced the closing of its initial public offering of common stock and the exercise by the underwriters of their over-allotment option to purchase an additional 2,399,998
SUNNYVALE, Calif., Sept. 11 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, announced today that Robert E. McNamara has resigned as chief financial officer and senior vice president to pursue other interests.
SUNNYVALE, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY) today announced the initial public offering of 16,000,000 shares of common stock, of which 10,000,000 are being sold by the Company and 6,000,000 are being sold by certain stockholders of the Company, at $18.00
SUNNYVALE, Calif. , June 26, 2023 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that as part of the annual reconstitution of the Russell stock indexes, the Company will be included in the Russell 2000 ® Index and the broad-market Russell 3000 ® Index, which will be effective
SUNNYVALE, Calif., April 26, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiosurgery, today announced the expiration of the mandatory, pre-merger waiting period under the Hart-Scott-Rodino (HSR) Antitrust Improvements Act of 1976, in
Partnership underscores widespread adoption of the CyberKnife System and IMPAC's commitment to vendor independent connectivity SUNNYVALE, Calif., Sept. 16 /PRNewswire-FirstCall/ -- Accuray Incorporated (Nasdaq: ARAY) and IMPAC Medical Systems, Inc. announced today that they will collaborate to
Acceptance of Accuray technologies in key markets adds to company's global market share SUNNYVALE, Calif. , April 3, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in adoption of its CyberKnife® and TomoTherapy® Systems in Europe , India , the Middle
SUNNYVALE, Calif., July 20, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), the premier radiation oncology company, will host a symposium examining best practices for quality assurance in radiation oncology at the 2011 Joint American Association of Physicists in Medicine
Leading Oncology Specialists Discuss Best Practices and Innovations in Cancer Treatment SUNNYVALE, Calif. , April 22, 2016 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that the Accuray Exchange in Radiation Oncology (AERO™) Users' Meeting was held April 10 – 11, 2016 at the
San Francisco Bay Area Innovators Gather to Discuss the Economic Impact on Local Healthcare Companies SUNNYVALE, Calif., June 24, 2011 /PRNewswire via COMTEX/ -- Accuray Incorporated (Nasdaq: ARAY), a global leader in the field of radiation oncology, today hosted a roundtable discussion on the
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
